Understanding risk factors for complications after leg artery treatment
Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion: a Prospective Observational Study
This study looks at patients with leg artery issues who have had a specific procedure to see what factors might lead to complications afterward.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University Academic / other |
| Locations | 1 site (Xian, Shaanxi) |
| Trial ID | NCT05586022 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with peripheral arterial occlusive disease (PAOD) who have undergone endovascular revascularization. It aims to identify risk factors associated with adverse cardiovascular and lower extremity outcomes following the procedure. The study will collect and analyze preoperative clinical data to better understand the challenges faced by vascular surgeons in managing complications. By examining the relationship between known risk factors and patient outcomes, the study seeks to improve treatment strategies for this common condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients with lower extremity arterial occlusive disease who have successfully undergone endovascular revascularization.
Not a fit: Patients with severe infections, tumors, liver and kidney failure, or autoimmune diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient outcomes and tailored treatment strategies for individuals with peripheral arterial occlusive disease.
How similar studies have performed: While this study addresses a common condition, the specific focus on risk factors for adverse outcomes in endovascular revascularization is relatively novel and has not been extensively tested in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with lower extremity arterial occlusive disease who underwent successful endovascular revascularization. * Preoperative baseline clinical data were complete. * Patients who completed the informed consent form. Exclusion Criteria: * Patients with severe infections, tumors, liver and kidney failure, and autoimmune diseases. * Patients with incomplete baseline data. * Patients lost to follow-up.
Where this trial is running
Xian, Shaanxi
- First Affiliated Hospital of Xi 'an Jiaotong University — Xian, Shaanxi, China (Recruiting)
Study contacts
- Principal investigator: Qingbin Zhao, Doctor — First Affiliated Hospital of Xi 'an Jiaotong University
- Study coordinator: Qingbin Zhao, Doctor
- Email: zhaoqingbin05@163.com
- Phone: 0086-029-85324043
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.